<DOC>
	<DOCNO>NCT02205905</DOCNO>
	<brief_summary>This open-label , single-dose , non-randomized study healthy male subject characterize mass balance , metabolic disposition , identification metabolite general metabolic pathway follow administration single dose IV solution contain 200 mg PER977 plus tracer amount 14C PER977 health male subject .</brief_summary>
	<brief_title>An Open-label , Single-dose , Non-randomized Study IV 14C-labeled PER977 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Male 2 . 1855 year age ( inclusive ) 3 . Body mass index 1832 kg/m2 ( inclusive ) minimum 50 kg ( 110 lb ) 4. voluntarily consent participate provide write informed consent prior start study specific procedures 5 . Willing able remain study unit entire duration confinement period 6 . Willing collect urine fecal sample duration study period require 7 . Will eat entire meal snack provide confinement research facility , understand diet include food high fiber content possibly prune juice 8 . Willing use waterless commode locate designated dry room urine feces collection duration study period require 9 . Willing abstain shower first 72 hour follow study drug administration . After restriction lift , willing provide urine sample prior shower remainder confinement period . 1 . History presence clinically significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , oncologic , psychiatric disease condition , opinion investigator , would jeopardize safety subject validity study result 2 . Clinically significant abnormal find physical exam , medical history , electrocardiogram clinical laboratory resutls screen 3 . History presence allergic adverse response anticoagulant reversal agent related drug 4 . Significantly abnormal diet within 4 week 5 . Donated blood plasma within 30 day 6 . Participated another clinical trial ( randomized subject ) within 30 day 7 . Participated radiolabeled clinical trial within last 12 month 8 . Used overthecounter medication , include nutritional supplement , within 7 day 9 . Used prescription medication within 14 day prior 10 . Treated known drug moderate strong inhibitors/inducers CYP enzymes barbiturate , phenothiazine , cimetidine , carbamazepine , etc . within 30 day 11 . Smoked used tobacco product within 60 day 12 . History substance abuse treatment ( include alcohol ) within past 2 year 13 . Positive urine screen drug abuse ( amphetamine , barbiturate , benzodiazepine , cocaine , cannabinoids , opiate ) cotinine screen checkin 14 . Positive test hepatitis B surface antigen , hepatitis C antibody human immunodeficiency virus screen previously treat hepatitis B , hepatitis C HIV infection 15 . Has irregular bowel habit 16 . Has significant radiation exposure within prior 12 month</criteria>
	<gender>Male</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>PER977</keyword>
	<keyword>metabolic disposition</keyword>
	<keyword>mass balance</keyword>
	<keyword>metabolite</keyword>
	<keyword>radiolabeled</keyword>
</DOC>